Skip to main content
Top
Published in: BMC Cancer 1/2003

Open Access 01-12-2003 | Research article

Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications

Authors: Mélanie Nugoli, Paul Chuchana, Julie Vendrell, Béatrice Orsetti, Lisa Ursule, Catherine Nguyen, Daniel Birnbaum, Emmanuel JP Douzery, Pascale Cohen, Charles Theillet

Published in: BMC Cancer | Issue 1/2003

Login to get access

Abstract

Background

Both phenotypic and cytogenetic variability have been reported for clones of breast carcinoma cell lines but have not been comprehensively studied. Despite this, cell lines such as MCF-7 cells are extensively used as model systems.

Methods

In this work we documented, using CGH and RNA expression profiles, the genetic variability at the genomic and RNA expression levels of MCF-7 cells of different origins. Eight MCF-7 sublines collected from different sources were studied as well as 3 subclones isolated from one of the sublines by limit dilution.

Results

MCF-7 sublines showed important differences in copy number alteration (CNA) profiles. Overall numbers of events ranged from 28 to 41. Involved chromosomal regions varied greatly from a subline to another. A total of 62 chromosomal regions were affected by either gains or losses in the 11 sublines studied. We performed a phylogenetic analysis of CGH profiles using maximum parsimony in order to reconstruct the putative filiation of the 11 MCF-7 sublines. The phylogenetic tree obtained showed that the MCF-7 clade was characterized by a restricted set of 8 CNAs and that the most divergent subline occupied the position closest to the common ancestor. Expression profiles of 8 MCF-7 sublines were analyzed along with those of 19 unrelated breast cancer cell lines using home made cDNA arrays comprising 720 genes. Hierarchical clustering analysis of the expression data showed that 7/8 MCF-7 sublines were grouped forming a cluster while the remaining subline clustered with unrelated breast cancer cell lines. These data thus showed that MCF-7 sublines differed at both the genomic and phenotypic levels.

Conclusions

The analysis of CGH profiles of the parent subline and its three subclones supported the heteroclonal nature of MCF-7 cells. This strongly suggested that the genetic plasticity of MCF-7 cells was related to their intrinsic capacity to generate clonal heterogeneity. We propose that MCF-7, and possibly the breast tumor it was derived from, evolved in a node like pattern, rather than according to a linear progression model. Due to their capacity to undergo rapid genetic changes MCF-7 cells could represent an interesting model for genetic evolution of breast tumors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Heim S, Teixeira MR, Dietrich CU, Pandis N: Cytogenetic polyclonality in tumors of the breast. Cancer Genet.Cytogenet. 1997, 95: 16-19. 10.1016/S0165-4608(96)00322-6.CrossRefPubMed Heim S, Teixeira MR, Dietrich CU, Pandis N: Cytogenetic polyclonality in tumors of the breast. Cancer Genet.Cytogenet. 1997, 95: 16-19. 10.1016/S0165-4608(96)00322-6.CrossRefPubMed
2.
go back to reference Flagiello D, Gerbault-Seureau M, Sastre-Garau X, Padoy E, Vielh P, Dutrillaux B: Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer [In Process Citation]. Genes Chromosomes Cancer. 1998, 23: 300-306. 10.1002/(SICI)1098-2264(199812)23:4<300::AID-GCC4>3.3.CO;2-E.CrossRefPubMed Flagiello D, Gerbault-Seureau M, Sastre-Garau X, Padoy E, Vielh P, Dutrillaux B: Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer [In Process Citation]. Genes Chromosomes Cancer. 1998, 23: 300-306. 10.1002/(SICI)1098-2264(199812)23:4<300::AID-GCC4>3.3.CO;2-E.CrossRefPubMed
3.
go back to reference Teixeira MR, Pandis N, Bardi G, Andersen JA, Mitelman F, Heim S: Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int.J.Cancer. 1995, 63: 63-68.CrossRefPubMed Teixeira MR, Pandis N, Bardi G, Andersen JA, Mitelman F, Heim S: Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int.J.Cancer. 1995, 63: 63-68.CrossRefPubMed
4.
go back to reference Visscher D, Dolan P, Ottosen S, Crissman J: Geographic distribution of co-dominant DNA stemlines in breast carcinoma. Cytometry. 1995, 21: 14-17.CrossRefPubMed Visscher D, Dolan P, Ottosen S, Crissman J: Geographic distribution of co-dominant DNA stemlines in breast carcinoma. Cytometry. 1995, 21: 14-17.CrossRefPubMed
5.
go back to reference Bonsing BA, Corver WE, Fleuren GJ, Cleton-Jansen AM, Devilee P, Cornelisse CJ: Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes Chromosomes Cancer. 2000, 28: 173-183. 10.1002/(SICI)1098-2264(200006)28:2<173::AID-GCC6>3.0.CO;2-1.CrossRefPubMed Bonsing BA, Corver WE, Fleuren GJ, Cleton-Jansen AM, Devilee P, Cornelisse CJ: Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes Chromosomes Cancer. 2000, 28: 173-183. 10.1002/(SICI)1098-2264(200006)28:2<173::AID-GCC6>3.0.CO;2-1.CrossRefPubMed
6.
go back to reference Soule HD, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973, 51: 1409-1416.PubMed Soule HD, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973, 51: 1409-1416.PubMed
7.
go back to reference Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff KK, Lippman ME: Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res. 1983, 43: 2223-2239.PubMed Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff KK, Lippman ME: Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res. 1983, 43: 2223-2239.PubMed
8.
go back to reference Whang-Peng J, Lee EC, Kao-Shan CS, Seibert K, Lippman M: Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. J Natl Cancer Inst. 1983, 71: 687-695.PubMed Whang-Peng J, Lee EC, Kao-Shan CS, Seibert K, Lippman M: Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. J Natl Cancer Inst. 1983, 71: 687-695.PubMed
9.
go back to reference Butler WB, Berlinski PJ, Hillman RM, Kelsey WH, Toenniges MM: Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res. 1986, 46: 6339-6348.PubMed Butler WB, Berlinski PJ, Hillman RM, Kelsey WH, Toenniges MM: Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res. 1986, 46: 6339-6348.PubMed
10.
go back to reference Osborne CK, Hobbs K, Trent JM: Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 1987, 9: 111-121.CrossRefPubMed Osborne CK, Hobbs K, Trent JM: Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 1987, 9: 111-121.CrossRefPubMed
11.
go back to reference Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J: Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. Proc Natl Acad Sci U S A. 1987, 84: 7295-7299.CrossRefPubMedPubMedCentral Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J: Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. Proc Natl Acad Sci U S A. 1987, 84: 7295-7299.CrossRefPubMedPubMedCentral
12.
go back to reference Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA: Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer. 2000, 83: 1309-1317. 10.1054/bjoc.2000.1458.CrossRefPubMedPubMedCentral Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA: Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer. 2000, 83: 1309-1317. 10.1054/bjoc.2000.1458.CrossRefPubMedPubMedCentral
13.
go back to reference Jones C, Payne J, Wells D, Delhanty JD, Lakhani SR, Kortenkamp A: Comparative genomic hybridization reveals extensive variation among different MCF-7 cell stocks. Cancer Genet Cytogenet. 2000, 117: 153-158. 10.1016/S0165-4608(99)00158-2.CrossRefPubMed Jones C, Payne J, Wells D, Delhanty JD, Lakhani SR, Kortenkamp A: Comparative genomic hybridization reveals extensive variation among different MCF-7 cell stocks. Cancer Genet Cytogenet. 2000, 117: 153-158. 10.1016/S0165-4608(99)00158-2.CrossRefPubMed
14.
go back to reference Courjal F, Cuny M, Rodriguez C, Louason G, Speiser P, Katsaros D, Tanner MM, Zeillinger R, Theillet C: DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br.J.Cancer. 1996, 74: 1984-1989.CrossRefPubMedPubMedCentral Courjal F, Cuny M, Rodriguez C, Louason G, Speiser P, Katsaros D, Tanner MM, Zeillinger R, Theillet C: DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br.J.Cancer. 1996, 74: 1984-1989.CrossRefPubMedPubMedCentral
15.
go back to reference Orsetti B, Courjal F, Cuny M, Rodriguez C, Theillet C: 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification [In Process Citation]. Oncogene. 1999, 18: 6262-6270. 10.1038/sj.onc.1203006.CrossRefPubMed Orsetti B, Courjal F, Cuny M, Rodriguez C, Theillet C: 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification [In Process Citation]. Oncogene. 1999, 18: 6262-6270. 10.1038/sj.onc.1203006.CrossRefPubMed
16.
go back to reference Courjal F, Theillet C: Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res. 1997, 57: 4368-4377.PubMed Courjal F, Theillet C: Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res. 1997, 57: 4368-4377.PubMed
17.
go back to reference Fitch WM: Toward defining the course of evolution: minimum change for a specific tree topology. Syst. Zool. 1971, 20: 406-416.CrossRef Fitch WM: Toward defining the course of evolution: minimum change for a specific tree topology. Syst. Zool. 1971, 20: 406-416.CrossRef
18.
go back to reference Swofford DL: PAUP*. Phylogenetic Analysis Using Parsimony (* and Other Methods). Version 4. 1998, Sunderland, Massachusetts, Sinauer Associates Swofford DL: PAUP*. Phylogenetic Analysis Using Parsimony (* and Other Methods). Version 4. 1998, Sunderland, Massachusetts, Sinauer Associates
19.
go back to reference Maddison WP, Maddison DR: MacClade: analysis of phylogeny and character evolution, version 3.04. 1992, Sunderland, MA, Sinauer Associates Maddison WP, Maddison DR: MacClade: analysis of phylogeny and character evolution, version 3.04. 1992, Sunderland, MA, Sinauer Associates
20.
go back to reference Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985, 39: 783-791.CrossRef Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985, 39: 783-791.CrossRef
21.
go back to reference Bremer K: Branch support and tree stability. Cladistics. 1994, 10: 295-304. 10.1006/clad.1994.1019.CrossRef Bremer K: Branch support and tree stability. Cladistics. 1994, 10: 295-304. 10.1006/clad.1994.1019.CrossRef
22.
go back to reference Bertucci F, Bernard K, Loriod B, Chang YC, Granjeaud S, Birnbaum D, Nguyen C, Peck K, Jordan BR: Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet. 1999, 8: 1715-1722. 10.1093/hmg/8.9.1715.CrossRefPubMed Bertucci F, Bernard K, Loriod B, Chang YC, Granjeaud S, Birnbaum D, Nguyen C, Peck K, Jordan BR: Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet. 1999, 8: 1715-1722. 10.1093/hmg/8.9.1715.CrossRefPubMed
23.
go back to reference Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.CrossRefPubMedPubMedCentral Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.CrossRefPubMedPubMedCentral
24.
go back to reference Pons M, Gagne D, Nicolas JC, Mehtali M: A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques. 1990, 9: 450-459.PubMed Pons M, Gagne D, Nicolas JC, Mehtali M: A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques. 1990, 9: 450-459.PubMed
25.
go back to reference Bertucci F, Viens P, Hingamp P, Nasser V, Houlgatte R, Birnbaum D: Breast cancer revisited using DNA array-based gene expression profiling. Int J Cancer. 2003, 103: 565-571. 10.1002/ijc.10867.CrossRefPubMed Bertucci F, Viens P, Hingamp P, Nasser V, Houlgatte R, Birnbaum D: Breast cancer revisited using DNA array-based gene expression profiling. Int J Cancer. 2003, 103: 565-571. 10.1002/ijc.10867.CrossRefPubMed
26.
go back to reference Kytola S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, Larsson C: Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer. 2000, 28: 308-317. 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B.CrossRefPubMed Kytola S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, Larsson C: Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer. 2000, 28: 308-317. 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B.CrossRefPubMed
27.
go back to reference Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R: MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 2001, 409: 355-359. 10.1038/35053094.CrossRefPubMed Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R: MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 2001, 409: 355-359. 10.1038/35053094.CrossRefPubMed
28.
go back to reference Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM, Kinzler KW, Vogelstein B, Lengauer C: Securin is required for chromosomal stability in human cells. Cell. 2001, 105: 445-457. 10.1016/S0092-8674(01)00340-3.CrossRefPubMed Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM, Kinzler KW, Vogelstein B, Lengauer C: Securin is required for chromosomal stability in human cells. Cell. 2001, 105: 445-457. 10.1016/S0092-8674(01)00340-3.CrossRefPubMed
29.
go back to reference Wang X, Jin DY, Ng RW, Feng H, Wong YC, Cheung AL, Tsao SW: Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 2002, 62: 1662-1668.PubMed Wang X, Jin DY, Ng RW, Feng H, Wong YC, Cheung AL, Tsao SW: Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 2002, 62: 1662-1668.PubMed
30.
go back to reference Saunders WS, Shuster M, Huang X, Gharaibeh B, Enyenihi AH, Petersen I, Gollin SM: Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A. 2000, 97: 303-308. 10.1073/pnas.97.1.303.CrossRefPubMedPubMedCentral Saunders WS, Shuster M, Huang X, Gharaibeh B, Enyenihi AH, Petersen I, Gollin SM: Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A. 2000, 97: 303-308. 10.1073/pnas.97.1.303.CrossRefPubMedPubMedCentral
31.
go back to reference Yoon DS, Wersto RP, Zhou W, Chrest FJ, Garrett ES, Kwon TK, Gabrielson E: Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am J Pathol. 2002, 161: 391-397.CrossRefPubMedPubMedCentral Yoon DS, Wersto RP, Zhou W, Chrest FJ, Garrett ES, Kwon TK, Gabrielson E: Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am J Pathol. 2002, 161: 391-397.CrossRefPubMedPubMedCentral
32.
go back to reference van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC: Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet. 2000, 9: 2973-2980. 10.1093/hmg/9.20.2973.CrossRefPubMed van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC: Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet. 2000, 9: 2973-2980. 10.1093/hmg/9.20.2973.CrossRefPubMed
33.
go back to reference Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H: Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res. 2000, 60: 6503-6509.PubMed Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H: Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res. 2000, 60: 6503-6509.PubMed
34.
go back to reference Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H: Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A. 2000, 97: 9603-9608. 10.1073/pnas.97.17.9603.CrossRefPubMedPubMedCentral Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H: Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A. 2000, 97: 9603-9608. 10.1073/pnas.97.17.9603.CrossRefPubMedPubMedCentral
35.
go back to reference Planet PJ, DeSalle R, Siddall M, Bael T, Sarkar IN, Stanley SE: Systematic analysis of DNA microarray data: ordering and interpreting patterns of gene expression. Genome Res. 2001, 11: 1149-1155. 10.1101/gr.187601.CrossRefPubMed Planet PJ, DeSalle R, Siddall M, Bael T, Sarkar IN, Stanley SE: Systematic analysis of DNA microarray data: ordering and interpreting patterns of gene expression. Genome Res. 2001, 11: 1149-1155. 10.1101/gr.187601.CrossRefPubMed
36.
go back to reference Larramendy ML, Lushnikova T, Bj]orkqvist AM, Wistuba ,II, Virmani AK, Shivapurkar N, Gazdar AF, Knuutila S: Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet. 2000, 119: 132-138. 10.1016/S0165-4608(99)00226-5.CrossRefPubMed Larramendy ML, Lushnikova T, Bj]orkqvist AM, Wistuba ,II, Virmani AK, Shivapurkar N, Gazdar AF, Knuutila S: Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet. 2000, 119: 132-138. 10.1016/S0165-4608(99)00226-5.CrossRefPubMed
37.
go back to reference Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 1997, 57: 1597-1604.PubMed Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 1997, 57: 1597-1604.PubMed
Metadata
Title
Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications
Authors
Mélanie Nugoli
Paul Chuchana
Julie Vendrell
Béatrice Orsetti
Lisa Ursule
Catherine Nguyen
Daniel Birnbaum
Emmanuel JP Douzery
Pascale Cohen
Charles Theillet
Publication date
01-12-2003
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2003
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-3-13

Other articles of this Issue 1/2003

BMC Cancer 1/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine